🔬An international consortium, led by #IRBBarcelona & the biotech company @MerusNV, reports the discovery of MCLA-158, the first clinical candidate screened in #organoids targeting 🎯 #cancer #stemcells of solid tumors.

📰@NatureCancer

➡️bit.ly/3MLiu3h

#IRBScience Image
Named Petosemtamab, the antibody MCLA-158 prevents the onset of #metastasis (that is, the spread of #cancer to other vital organs) and slows the growth of primary tumours in experimental models of cancer. Image
The study also lays the groundwork for the use of #organoids in the #DrugDiscovery process undertaken by pharmaceutical companies.

Organoids are patient-derived samples that can be grown in the laboratory, and they reproduce certain aspects of the tumour compartment. Image
For the development and characterisation of this antibody, researchers from HUB Organoids built a large biobank comprising organoids derived from patients with colon cancer, organoids from colon cancer metastasis to the liver, and organoids from normal non-cancerous tissue. Image
Dr. @BatlleLab: "It's highly satisfying to see that our discoveries are helping patients. We started studying cancer stem cells 15 years ago. The journey has been exciting & very complex. It has required a large investment of resources & great deal of work by many researchers. Image
This research includes work developed in the suppresSTEM consortium, funded by the EU & w/ collaborative work by research centres #IRBBarcelona
@_Hubrecht @sangerinstitute & companies (@MerusNV Ocello B.V./@crownbioscience). @VHIO @ICO_oncologia & @Xenopat_ collaborated in data. Image

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with IRB Barcelona

IRB Barcelona Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @IRBBarcelona

Sep 22, 2020
#IRBScience: Published in @GenomeMedicine, the latest work from the SBNB lab points to the co-occurrence of #cancer driver genes as a key to precision medicine.

Read👓the news➡️bit.ly/2RP3WFf

(1/4) Follow this thread to learn more ↘️
#WorldCancerResearchDay
The system is called Targeted Cancer Therapy for You (TCT4U), and it's aimed at predicting tumour response to different treatments.💊

It has allowed the identification of a set of complex biomarkers🧬that have now been made available to the medical-scientific community.

(2/4)↘️
"The sum of two or more mutated #Cancer driver genes affects the tumour's response to treatments" says @ptck72, "through this work, we see that studying cancer driver genes as a whole can bring about a great advance towards precision medicine".

#WorldCancerResearchDay
(3/4)↘️
Read 4 tweets
Sep 21, 2020
Today is #WorldAlzheimersDay 🧠 and this disease has been on #IRBBarcelona's agenda since its start.

@Eduard_puig is one of the committed scientists who recently made an important contribution to the field.
(1/4)
In June, @Eduard_puig, @SoniaCiudad and Natalia Carulla, among others, revealed the specific ensembles of Aβ protein that have the capacity to disrupt the membrane of neurons, causing their death.

➡️bit.ly/3clhW34
#IRBScience #WorldAlzheimersDay
(2/4)
In fact, the @ShorterLab, one of the 🔝groups in protein aggregation, published a review on their work in @TrendsNeuro.

➡️cell.com/trends/neurosc…
#WorldAlzheimersDay
(3/4)
Read 4 tweets
Sep 7, 2020
The Evomet project, coordinated by #IRBBarcelona, will train future leaders in metastasis research.

Read the news➡️bit.ly/324VEid

Follow this thread to meet the labs participating⬇️
(1/9)
At @IRBBarcelona, the Growth Control and Cancer Metastasis lab, led by @RogerGom1, will be hosting two students.
irbbarcelona.org/en/research/gr…

@MarionaGraupera will also mentor two students in the Vascular Signaling Lab, which she leads at @idibell_cat. procure-ico.eu/mariona-graupe…
(2/9)
At @IMPvienna, @obenaufa will be training one of the future leaders in metastasis research, in the Obenauf lab obenauflab.com

A position is available alongside @ClareIsacke, Head of the Molecular Cell Biology team at @ICR_London.
icr.ac.uk/our-research/r…
(3/9)
Read 9 tweets
Sep 4, 2020
@IRBBarcelona coordinates the European Project Evomet to train 15 young scientists and future leaders in metastasis research with the aim to identify therapeutic solutions. The project has received €4 M and will last for four years.

irbbarcelona.org/en/news/irb-ba…
Each of the institutions will host one of the selected young researchers and will train them until they complete their doctorate, except for @IRBBarcelona and @idibell_cat IDIBELL, which will host two predoctoral researchers each.
Read 4 tweets
Aug 17, 2020
#IRBScience: The @bbglab publishes "A compendium of mutational cancer driver genes" in @NatureRevCancer, with mportant implications in clinical decision making.

📢568 genes identified with the potential to trigger #cancer!

➡️bit.ly/2DUxvSn
(1/5) @nlbigas @fran_mj88
The study stands on the analysis of the genomes of 28,000 tumours from 66 types of cancer and it's a major update of the #IntOGen platform (intogen.org), aimed at identifying mutational cancer driver genes.

(2/5)
“The compendium of driver genes provides cancer researchers, both in the clinical and basic research setting, with crucial knowledge and it has an important impact on clinical decision-making,” says @nlbigas, head of the @bbglab at @IRBBarcelona and @icreacommunity.

(3/5)
Read 5 tweets
Aug 5, 2020
📢TLK protein inhibition activates the innate #ImmuneSystem, thus becoming a potential therapeutic target for enhancing the effect of some #cancer treatments.

The latest study from @genstability lab is now out in @CellReports.

➡️bit.ly/2PoObDR
#IRBScience
(1/2) Image
“The activation of innate immunity in cancer has recently become an active area of ​​research as it has become clear that the innate immune response influences chemotherapy and immunotherapy,” comments @genstability, who recently took up a new position at @theNCI.
(2/4) Image
“This could help us understand our previous observation that TLK depletion caused replication stress and help us exploit the effects of TLK depletion for cancer therapy,” says @ssurebayona, first author of the study, now a postdoc at @TheCrick and #IRBAlumni.
(3/4) Image
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us on Twitter!

:(